Month: March 2022

The Nashville-based driver and safety advocate is Yellow’s first finalist for Driver of the Year.Peggy Arnold Yellow driver and finalist for Women In Trucking’s 2022 Driver of the YearNASHVILLE, Tenn., March 11, 2022 (GLOBE NEWSWIRE) — Peggy Arnold, a company driver for Yellow Corporation (NASDAQ: YELL) for nearly 30 years, is one of three finalists for the 2022 Driver of the Year award, the Women In Trucking Association (WIT) announced this week. The third annual award recognizes outstanding female professional drivers who are industry leaders in safety standards and service, while also enhancing the trucking profession’s public image. The award winner will be announced on March 25 during WIT’s “Salute to Women Behind the Wheel” event at the Mid-America Trucking Show (MATS) in Louisville, Ky. Arnold will attend the event. “It’s...

CHICAGO and VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise dispensaries, today announced the resignation of Wes Moore from its board of directors. Moore joined Green Thumb’s board of directors in 2018 and served on the audit and compensation committee. “On behalf of our entire team, I’d like to thank Wes for his many contributions to Green Thumb,” said Founder and Chief Executive Officer Ben Kovler. “As an entrepreneur, executive, combat veteran and social advocate, Wes has provided us with invaluable perspective and leadership, and we appreciate his dedication to our mission and his dedication to equity in the industry and social justice.” Wes Moore added: “I am grateful...

DENVER and VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) announces that it has amended the terms of an unsecured convertible debenture previously issued on February 12, 2021 to an arm’s length investor in the principal amount of $600,000 (the “Convertible Debenture”). The Convertible Debenture bears interest at the rate of 15% per annum and matured on October 1, 2021; under the amended terms, the Convertible Debenture will now mature on October 1, 2022 and it will be convertible into units (each, a “Unit”) of the Company with a conversion price of $0.13 per Unit. Each Unit will be comprised of one common share (each, a “Share”) and one Share purchase warrant that is exercisable to acquire one additional Share at a price...

FREMONT, Calif., March 11, 2022 (GLOBE NEWSWIRE) — ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today commented on recent announcements made by the U.S. Securities and Exchange Commission (SEC) regarding the U.S. Holding Foreign Companies Accountable Act of 2020 (HFCAA). On March 8, 2022, the SEC published its first “Provisional list of issuers identified under the HFCAA.” ACM was identified on the SEC’s provisional list after ACM filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which includes an audit report issued by a public accounting firm that the PCAOB is unable to inspect because of regulations in China. ACM appeared relatively early on the SEC’s provisional list after the filing...

2021 Revenue of $1,167 million, in-line with guidance Loss per Share of $0.34 in the fourth quarter of 2021 On track for $50 million in cash flow improvements in 2022 Long-term debt(1) reduced by $454 million Small-and-Medium-Sized Business “SMB” continues robust growth in the fourth quarter of 2021 with DMR customers growing 44% sequentially and DrySign® users growing 135% sequentiallyConference call scheduled for March 11, 2022 at 2:00 PM ET IRVING, Texas, March 11, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a global business process automation (“BPA”) leader, announced today its financial results for the fourth quarter and full year ended December 31, 2021. “We are pleased with our execution and meeting our latest revenue expectations for the full year 2021 while also producing...

Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new customersOxford, UK – 11 March 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or the “Company”), a leading gene and cell therapy group, is pleased to announce that it has completed its deal with Homology Medicines Inc. (Nasdaq: FIXX) (“Homology”), a genetic medicines company, to establish Oxford Biomedica Solutions LLC, a new US-based full scope, Adeno-Associated Virus (AAV) manufacturing and innovation business. The new Oxford Biomedica Solutions business is fully operational and offers a proprietary ‘plug and play’ platform that is capable of achieving both high titre and high product quality vector for customers. The platform has already been proven with three separate new...

UPPSALA, SWEDEN – LIDDS AB (publ)’s (“LIDDS” or the “Company”) Extraordinary General Meeting was held 11 March 2022 in the Company’s premises in Uppsala. The Extraordinary General Meeting resolved as set out below. Authorisation to issue convertiblesThe Extraordinary General Meeting resolved in accordance with the Board of Directors’ proposal to authorise the Board of Directors to, within the scope of the articles of association, with deviation from the shareholders’ pre-emption rights, on one or several occasions during the period until the next Annual General Meeting, resolve to issue convertibles in the Company. Such issue may only be made in accordance with the financing agreement that the Company entered into with Nice & Green S.A. on 22 February 2022 and on the terms further described in the Board of Directors’ proposal to...